Fulcrum Therapeutics (FULC) Receivables - Other (2020 - 2025)
Fulcrum Therapeutics (FULC) posted Receivables - Other of $979,000 for Q1 2025, down 53.3% from the prior quarter.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) Receivables - Other (2020 - 2025) Analysis & Trends
At the end of FY2024, Fulcrum Therapeutics' Receivables - Other came in at $2.1 million, up 290.3% from FY2023.
- Annual Receivables - Other shows a four-year compound annual growth rate of 41.0% (FY2020 to FY2024).
- In prior years, Fulcrum Therapeutics' Receivables - Other was $537,000 in FY2023 (+134.5%), $229,000 in FY2022 (-90.8%), $2.5 million in FY2021 (+370.8%) and $531,000 in FY2020.
- The Q1 2025 figure stands as the lowest quarterly Receivables - Other since Q4 2023.
- On a year-over-year basis, Receivables - Other increased in four of the last six quarters, with growth averaging 195.4%.
- The strongest year-over-year quarter for Receivables - Other in the past five years was Q3 2024, with growth of 530.3%; the weakest was Q4 2022, with a decline of 90.8%.
- According to Business Quant data, Receivables - Other for the three prior quarters was $2.1 million (Q4 2024), $3.66 million (Q3 2024) and $2.33 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Fulcrum Therapeutics | 283.78 Mn | -59.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 979,000.00 |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 3.66 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Dec 31, 2023 | 537,000.00 |
| Sep 30, 2023 | 580,000.00 |
| Jun 30, 2023 | 656,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Dec 31, 2022 | 229,000.00 |
| Sep 30, 2022 | 790,000.00 |
| Jun 30, 2022 | 743,000.00 |
| Mar 31, 2022 | 802,000.00 |
| Dec 31, 2021 | 2.50 Mn |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 657,000.00 |
| Mar 31, 2021 | 532,000.00 |
| Sep 30, 2020 | 592,000.00 |
| Jun 30, 2020 | 755,000.00 |
| Mar 31, 2020 | 325,000.00 |
API Access
Fulcrum Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();